SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-164486
Filing Date
2023-06-09
Accepted
2023-06-09 16:30:54
Documents
12
Period of Report
2023-06-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d513689d8k.htm   iXBRL 8-K 36661
  Complete submission text file 0001193125-23-164486.txt   163337

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sldb-20230606.xsd EX-101.SCH 2853
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sldb-20230606_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sldb-20230606_pre.xml EX-101.PRE 11709
6 EXTRACTED XBRL INSTANCE DOCUMENT d513689d8k_htm.xml XML 3473
Mailing Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129
Business Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129 617-337-4680
Solid Biosciences Inc. (Filer) CIK: 0001707502 (see all company filings)

IRS No.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38360 | Film No.: 231005802
SIC: 2836 Biological Products, (No Diagnostic Substances)